Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
avian influenza
Pharma
BARDA signs on with CSL Seqirus for 4.8M bird flu shots
CSL Seqirus has won its fourth award from the U.S. Department of Health and Human Services related to avian flu pandemic preparedness activities.
Kevin Dunleavy
May 30, 2024 2:32pm
CSL Seqirus to trial avian vaccine candidate in $30M BARDA deal
Oct 10, 2022 10:39am
Daiichi Sankyo comes up far short in avian flu vaccine effort
May 22, 2019 10:19am
HKEX, Zai Lab, WuXi and more—FiercePharmaAsia
Aug 31, 2018 9:05am
China has withheld deadly bird flu samples from U.S.: NYT
Aug 28, 2018 11:53am
NIH pushes Sanofi’s new H7N9 bird flu vaccine into human tests
Mar 21, 2018 9:25am
